KactusBio Inc.

Vaccinia Capping Enzyme GMP-Grade (GMP-VCS-VE101) DMF #038028

Product Code:
 
KAC-GMP-VCS-VE101
Supplier:
 
KactusBio Inc.
Regulatory Status:
 
GMP grade
Shipping:
 
Shipped with blue ice.
Storage:
 
-20?5°C for 24 months. Avoid repeated freeze-thaw cycles.
1 / 1
Figure 1. Analysis of mRNA capping efficiency using LC-MS.
❮❯

Figure 1. Analysis of mRNA capping efficiency using LC-MS.

No additional charges, what you see is what you pay! *

CodeSizePrice
KAC-GMP-VCS-VE101-11-10KU10KU£2,612.00
Quantity:
KAC-GMP-VCS-VE101-13-1MU1MU£139,266.00
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges to UK mainland customers, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 14-21 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • Show All

Further Information

Description:
The 7-methylguanosine cap structure (m7Gppp, Cap0) is a specific feature in eukaryotic mRNA, which is required for mRNA stability, splicing, nuclear export, effective translation, and mRNA decay. Vaccinia Capping Enzyme, a heterodimer of D1 and D12 subunits, adding the Cap0 structure to the 5' end of the RNA. The D1 subunit comprises an N-terminal RNA triphosphatase (TPase), a guanylyltransferase (GTase), and a C-terminal guanine-N7-methyltransferase (MTase). The D12 subunit binds and stimulates the MTase.

NOTE: mRNA Cap 2'-O-Methyltransferase (Kactus #GMP-MEH-VE101) is required to generate Cap 1 structure that reduces cellular innate immune response when the RNA is used in vivo .

This product has been filed with the FDA Drug Master Files (DMF) and is assigned DMF #038028.
Formulation:
Liquid

Documents